NCT04141618

Brief Summary

Development of mole was not associated with segregation of mutated NLRP7 allele in the haploid oocyte. We hypothesize NLRP7 is a maternal factor involved in regulating early embryo development or embryo-uterine interaction. In the proposed study, we seek to identify novel genetic variants and mutations of NLRP7 in women who experienced RM/HM. Genetic association study and haplotype analysis are performed to test assocation between NLRP7 gene and female reproductive performance. Immunohistochemical staining, RT-PCR, and Western blot analysis are used to investigate expression pattern of NLRP7 in endometrium and placenta. Two approaches are used to characterize functional significance of genetic variants/mutations. The first approach will be based on mutagenesis and the second approach will be based on induced pluripotent stem cells (iPSCs). Results obtained from the proposed study will provide novel insight into mechanism of embryo development and implantation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
143

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Aug 2011

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2011

Completed
2.7 years until next milestone

First Submitted

Initial submission to the registry

April 7, 2014

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2015

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2015

Completed
4.2 years until next milestone

First Posted

Study publicly available on registry

October 28, 2019

Completed
Last Updated

October 4, 2022

Status Verified

October 1, 2019

Enrollment Period

3.9 years

First QC Date

April 7, 2014

Last Update Submit

October 3, 2022

Conditions

Keywords

recurrent miscarriageinfertility

Outcome Measures

Primary Outcomes (1)

  • pregnancy outcome

    Pregnancy and delivery of a normal baby is defined as normal outcome

    1 month at the end of pregnancy

Secondary Outcomes (1)

  • spontaneous abortion

    abortion before 12 weeks of gestation

Other Outcomes (1)

  • intrauterine fetal death

    fetal death after 12 weeks of gestation

Eligibility Criteria

Age25 Years - 45 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

Assuming that there are 300 cases and 300 controls enrolled, the underlying disease model is recessive, the disease prevalence is approximately 3% and the disease allele frequency is about 5%, this study has more than 80% power for detecting the SNP with an allele frequency greater than 10% and an allelic odds ratio greater than 1.4. We assumed that the SNP is either the causal gene or in LD with the causal allele and power was calculated without multiple testing corrections.

You may qualify if:

  • Recurrent abortions and infertility treatments but combined with repetitive (more than two consecutive) implantation failure couples, rather than general infertility couples.

You may not qualify if:

  • Women who do not have recurrent miscarriage and infertility problems.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Cheng-Kung University Hospital

Tainan, 70428, Taiwan

Location

Biospecimen

Retention: SAMPLES WITH DNA

DNA extracted from peripheral blood.

MeSH Terms

Conditions

Abortion, HabitualInfertility

Condition Hierarchy (Ancestors)

Abortion, SpontaneousPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital Diseases

Study Officials

  • Pao-Lin Kuo, MD

    Department of Obstetrics and Gynecology, National Cheng Kung University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 7, 2014

First Posted

October 28, 2019

Study Start

August 1, 2011

Primary Completion

July 1, 2015

Study Completion

July 31, 2015

Last Updated

October 4, 2022

Record last verified: 2019-10

Locations